View in EDS PDF Full Text

Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?

Saved in:
Bibliographic Details
Title: Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?
Authors: Awidi M; Roswell Park Comprehensive Cancer Center, Buffalo, NY. Electronic address: Muhammad.awidi@roswellpark.org., Mier-Hicks A; Texas Oncology, Dallas, TX., Perimbeti S; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Attwood K; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Chen H; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Jain P; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Yau E; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Early A; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Dy GK; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Source: Clinical lung cancer [Clin Lung Cancer] 2024 Sep; Vol. 25 (6), pp. 509-518. Date of Electronic Publication: 2024 May 29.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38879394
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Awidi+M%22">Awidi M</searchLink>; Roswell Park Comprehensive Cancer Center, Buffalo, NY. Electronic address: Muhammad.awidi@roswellpark.org.<br /><searchLink fieldCode="AU" term="%22Mier-Hicks+A%22">Mier-Hicks A</searchLink>; Texas Oncology, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22Perimbeti+S%22">Perimbeti S</searchLink>; Roswell Park Comprehensive Cancer Center, Buffalo, NY.<br /><searchLink fieldCode="AU" term="%22Attwood+K%22">Attwood K</searchLink>; Roswell Park Comprehensive Cancer Center, Buffalo, NY.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; Roswell Park Comprehensive Cancer Center, Buffalo, NY.<br /><searchLink fieldCode="AU" term="%22Jain+P%22">Jain P</searchLink>; Roswell Park Comprehensive Cancer Center, Buffalo, NY.<br /><searchLink fieldCode="AU" term="%22Yau+E%22">Yau E</searchLink>; Roswell Park Comprehensive Cancer Center, Buffalo, NY.<br /><searchLink fieldCode="AU" term="%22Early+A%22">Early A</searchLink>; Roswell Park Comprehensive Cancer Center, Buffalo, NY.<br /><searchLink fieldCode="AU" term="%22Dy+GK%22">Dy GK</searchLink>; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100893225%22">Clinical lung cancer</searchLink> [Clin Lung Cancer] 2024 Sep; Vol. 25 (6), pp. 509-518. <i>Date of Electronic Publication: </i>2024 May 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100893225 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0690 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215257304%22">15257304 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lung Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38879394
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cllc.2024.05.003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 509
    Titles:
      – TitleFull: Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Awidi M
      – PersonEntity:
          Name:
            NameFull: Mier-Hicks A
      – PersonEntity:
          Name:
            NameFull: Perimbeti S
      – PersonEntity:
          Name:
            NameFull: Attwood K
      – PersonEntity:
          Name:
            NameFull: Chen H
      – PersonEntity:
          Name:
            NameFull: Jain P
      – PersonEntity:
          Name:
            NameFull: Yau E
      – PersonEntity:
          Name:
            NameFull: Early A
      – PersonEntity:
          Name:
            NameFull: Dy GK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0690
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical lung cancer
              Type: main
ResultId 1